Project Grant HT94252410875
Award Date
8/1/24
Completion Date
7/31/26
Dollars Obligated
$250K
Federal Agency
Defense Health Agency
Awardee
Emory University (S352L5PJLMP8)
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Atlanta, GA 30322, USA
Similar Awards
Emory University will receive $1,468,033 from the Department of the Army Medical Command under the Military Medical Research and Development federal grant program (CFDA 12.420) to accelerate translation of a small molecule enhancer to promote recovery and reduce neuropathic pain after spinal cord injury using a pig model. The three-year project grant award beginning September 30th, 2022 will support Emory University's work investigating medical solutions for the battlefield by transforming...
The Defense Health Agency awarded Emory University a $305,175 Project Grant under the Military Medical Research and Development program (CFDA 12.420) to conduct research on a novel therapeutic target for renal medullary carcinoma. The award period runs from July 1, 2023 to June 30, 2026. As a leading research university, Emory has a strong track record of delivering scientific research and public health services under federal grants and contracts. This award supports Emory's expertise in...
This $249,960 Project Grant award from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) supports research conducted by The Ohio State University to investigate the effects of the aged inflammatory central nervous system (CNS) microenvironment on oligodendroglial properties and remyelination capacity. The research aims to advance scientific understanding of age-related changes in the CNS that can impact myelin repair, with potential applications for...
This Project Grant, awarded by the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420), provides $625,994 to Emory University to support research on novel cell therapy approaches for neuroblastoma. The project aims to advance the development of new treatments for this type of pediatric cancer, which is a priority area for military medical research. Emory University, a leading academic research institution, is well-positioned to conduct this work,...
The Defense Health Agency awarded Emory University a $2,324,087 Project Grant under the Military Medical Research and Development (CFDA 12.420) program. The grant, titled "ELECTRIG: EVALUATING EFFECTS OF CRANIAL ELECTRICAL STIMULATON THERAPY WITH RESPONSIVE IMAGING IN GULF WAR ILLNESS PAIN AND COMORBID SYMPTOMS", will support advanced biomedical research to investigate innovative medical solutions for military personnel and the broader public. The 4-year project aims to transform...
The U.S. Defense Health Agency awarded a $792,500.00 Project Grant to Temple University-Of The Commonwealth System Of Higher Education, through its division Temple University-Of The Commonwealth System Of Higher Educa and doing business as Temple University, for the purpose of "AN EFFECTIVE STRATEGY TO PROMOTE AXON REGENERATION AND FUNCTIONAL RECOVERY AFTER SPINAL CORD INJURY". The Project Grant is funded through the U.S. Military Medical Research and Development program (CFDA 12.420),...
This federal Project Grant award from the Department of Defense's Military Medical Research and Development program (CFDA 12.420) in the amount of $1,765,321.00 was awarded to the University of Miami on September 30, 2023. The funding supports a four-year research project to develop functionalized peptide gels and utilize Schwann cells for repairing injured spinal cords. The University of Miami is the prime grantee and may collaborate with other research institutions as sub-grantees to execute...
Emory University was awarded a $159,929 Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The grant will fund whole-genome structural variation and CpG methylation analyses through long-read sequencing from April 1, 2023 to March 31, 2025. The Military Medical Research and Development program supports basic, applied, and advanced biomedical research to transform military and public health care through innovative medical...
The Defense Health Agency awarded Emory University a $156,500 project grant under the Military Medical Research and Development program to support research on core transcription factors in regenerative medicine and cancer. The one-year award beginning September 30, 2023 will fund investigation into medical solutions for the battlefield by transforming healthcare through innovative biomedical research. Specifically, Emory University will conduct research on core transcription factors as they...
The Defense Health Agency awarded a $1,332,764 Project Grant to Neurocreis, Inc. in College Station, TX under the Military Medical Research and Development (CFDA 12.420) program. The grant supports the "Therapeutic Development of NC101 for Promoting Neurological Recovery After Chronic SCI", with a performance period from July 1, 2025 to June 30, 2028. The funding will enable Neurocreis to conduct advanced biomedical research aimed at transforming healthcare for military service...